forecast

Obesity Drugs Created About $1 Trillion Temporarily

Eli Lilly and Novo Nordisk have together created roughly $1 trillion in market value by addressing obesity, but this value is temporary because it will shrink back toward zero when Ozempic's patents expire in about 15 years, unlike Microsoft's long-lived franchise.

forecastpending

Speaker

Rod

Evidence Quote

“in 15 years when the patents expire on Ozempic, it's going back to 0.”

Source

RTW: Investing Across Healthcare— Business Breakdowns
Created: 11/13/2026, 1:54:32 PM

Your notes

Loading notes...